Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
RX-3117
print preview
bookmark
share with colleague
General Information
Company
Rexahn Pharmaceuticals Inc.
Description
Small molecule nucleoside inhibitor of DNA methyltransferase, a cyclin dependent kinase (CDK) and DNA synthesis
Molecular Target
DNA methyltransferase
Mechanism of Action
Cyclin dependent kinase (CDK) inhibitor; DNA methyltransferase inhibitor; DNA repair inhibitor
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Disease Category
Standard Indication
Indication Details
Partners
Milestones
Latest Stage of Development
More
Archive Items are loading
Set Email Alert
dummy